Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Q32 Bio (QTTB) Consolidated Net Income (2018 - 2025)

Historic Consolidated Net Income for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to -$7.4 million.

  • Q32 Bio's Consolidated Net Income rose 5800.51% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.1 million, marking a year-over-year increase of 2878.75%. This contributed to the annual value of -$46.1 million for FY2024, which is 1420.65% up from last year.
  • According to the latest figures from Q3 2025, Q32 Bio's Consolidated Net Income is -$7.4 million, which was up 5800.51% from -$9.5 million recorded in Q2 2025.
  • Q32 Bio's 5-year Consolidated Net Income high stood at $92.7 million for Q1 2022, and its period low was -$34.6 million during Q4 2022.
  • Its 5-year average for Consolidated Net Income is -$11.8 million, with a median of -$14.2 million in 2024.
  • Per our database at Business Quant, Q32 Bio's Consolidated Net Income soared by 873588.07% in 2022 and then crashed by 101543.57% in 2025.
  • Over the past 5 years, Q32 Bio's Consolidated Net Income (Quarter) stood at -$33.6 million in 2021, then dropped by 2.94% to -$34.6 million in 2022, then increased by 21.33% to -$27.2 million in 2023, then surged by 47.83% to -$14.2 million in 2024, then skyrocketed by 47.92% to -$7.4 million in 2025.
  • Its Consolidated Net Income was -$7.4 million in Q3 2025, compared to -$9.5 million in Q2 2025 and -$11.0 million in Q1 2025.